Meta-analysis of nine studies (80% low-grade and 20% grade 4) concerning the impact of CDKN2A HD in astrocytomas. They found CDKN2A HD was predictive for OS. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).